Piceatannol, Syk tyrosine kinase inhibitor
Be the first to review this product! Submit a review
|
(4 Publications)
- FuncS
Unknown
Functional Studies - Piceatannol, Syk tyrosine kinase inhibitor (AB120722)
ab119954 staining CBL in A431 cells treated with piceatannol (ab120722), by ICC/IF. Decrease in CBL expression correlates with increased concentration of piceatannol, as described in literature.
The cells were incubated at 37°C for 1h in media containing different concentrations of ab120722 (piceatannol) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab119954 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight® 488 goat anti-mouse polyclonal antibody (ab96879) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.
- Chemical Structure
Lab
Chemical Structure - Piceatannol, Syk tyrosine kinase inhibitor (AB120722)
2D chemical structure image of ab120722, Piceatannol, Syk tyrosine kinase inhibitor
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in immunology 12:602067 PubMed33732234
2021
Applications
Unspecified application
Species
Unspecified reactive species
Antimicrobial agents and chemotherapy 61: PubMed28652233
2017
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 7:8120 PubMed28808303
2017
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 7:2831 PubMed28588201
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com